Cytek Biosciences, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Cytek Biosciences, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2020 to Q3 2024.
  • Cytek Biosciences, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 131M shares, a 3.8% decline year-over-year.
  • Cytek Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 135M shares, a 0.57% increase from 2022.
  • Cytek Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 135M shares, a 75.3% increase from 2021.
  • Cytek Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 76.7M shares, a 163% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 131M -5.17M -3.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 131M -4.48M -3.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 131M -4.57M -3.37% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 135M +772K +0.57% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 136M +1.46M +1.09% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 136M +1.52M +1.13% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 135M +1.59M +1.19% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 135M +57.8M +75.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 135M +26.4M +24.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 134M +103M +322% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 134M +102M +324% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 76.7M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-13
Q3 2021 108M +79.6M +277% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 31.9M +3.38M +11.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 31.6M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 28.7M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 28.5M Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.